Severe Androgenetic Alopecia as a Marker of Metabolic Syndrome in Male Patients: A Hospital-Based Case Control Study

    Mohd Rafiq Tilwani, Naina Dogra, Devraj Dogra, Suhail Raheem Rather, Parvaiz Anwar Rather
    Image of study
    TLDR Men with severe hair loss are more likely to have metabolic syndrome, a condition linked to heart disease.
    In a 2017 hospital-based case control study involving 100 male patients with androgenetic alopecia (AGA), researchers found a significant association between severe AGA and metabolic syndrome (MS). The study, which included a control group of age and sex-matched individuals, revealed that MS was 4.6 times more common in patients with AGA compared to the control group. Furthermore, MS was significantly more prevalent in patients with severe AGA compared to those with mild-moderate AGA. Among the evaluated parameters of MS, such as blood pressure, fasting blood sugar, and dyslipidemia, all were significantly more common in AGA patients compared to controls, except for abdominal obesity. The findings suggest that patients with severe AGA are at a higher risk of developing MS and other cardiovascular diseases.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community Do we have to be junkies? That's funny

      in Research/Science  13 upvotes 6 months ago
      The conversation discusses using finasteride, dutasteride, minoxidil, cialis, and metformin to protect hair and health. Some users caution against self-prescribing these drugs due to potential risks and complications.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 7 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

      community I am a dermatologist with a clinical interest in alopecia. AMA

      in Will treatment work for me? 2 years ago
      In this conversation, 4990 discussed various treatments for hair loss, including oral minoxidil, PRP, transplan, Jak inhibitors, Dutasteride, Finasteride, Olumiant, Ketoconazole, RU58841, microneedling, baricitinib, and CCCA. They recommended scalp biopsies in unclear cases of DUPA, twice weekly to twice daily shampooing for topical minoxidil users, and two sessions spaced one month apart with follow up at month three to determine the effectiveness of PRP treatment.
      [object Object]

      community Being Safe on Oral Minoxidil: tl;dr on the literature.

      in Research/Science  47 upvotes 2 weeks ago
      Oral minoxidil is effective for hair loss but can cause cardiovascular side effects, such as pericardial effusion, especially in those with genetic predispositions. Starting with low doses and monitoring cardiovascular health are advised to reduce risks.

      community Why is everyone not directly advised Dutasteride?

      in Finasteride/Dutasteride  168 upvotes 3 months ago
      Dutasteride is less commonly prescribed for hair loss because it is not FDA-approved for this purpose, unlike finasteride, which is more accessible and preferred due to fewer side effects. Dutasteride may be more effective in reducing DHT but has a longer half-life and potentially more significant side effects.

    Related Research

    18 / 18 results